Lv55
1440 积分 2024-05-09 加入
Development of an Improved Process To Prepare a Key Intermediate in the Manufacture of Sotorasib
6小时前
待确认
An Efficient Second-Generation Manufacturing Process for the pan-RAF Inhibitor Belvarafenib
7小时前
待确认
Preclinical Toxicology Supply for a Complex API Enabled by Asymmetric Catalysis and Rapid Chemical Development: IL-17A Inhibitor LY3509754
8小时前
待确认
Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part III. Assembly of Drug Substance, Salt Formation, and Impurity Control
8小时前
待确认
Abstract 503: ISM3412, a novel and selective MAT2A inhibitor for the treatment of cancer
1个月前
已关闭
Discovery of Novel SIK2/3 Inhibitors for the Potential Treatment of MEF2C+ Acute Myeloid Leukemia (AML)
2个月前
已完结
Research Progress in DNA Damage Response (DDR)-Targeting Modulators: from Hits to Clinical Candidates
3个月前
已完结
A Unified Approach to Decarboxylative Halogenation of (Hetero)aryl Carboxylic Acids
4个月前
已完结
Discovery of an Efficacious RET PROTAC Degrader with Enhanced Antiproliferative Activity against Resistant Cancer Cells Harboring RET Solvent-Front Mutations
5个月前
已完结
Protein degraders push into novel target space
5个月前
已完结
皖公网安备34019202002308
